SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-16-003247
Filing Date
2016-10-18
Accepted
2016-10-18 16:01:08
Documents
1
Period of Report
2016-10-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 10834
  Complete submission text file 0001562180-16-003247.txt   12202
Mailing Address C/O BIOMARIN PHARMACEUTICAL INC. 371 BEL MARIN KEYS BLVD., SUITE 210 NOVATO CA 94949
Business Address
KAKKIS EMIL D (Reporting) CIK: 0001248093 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36276 | Film No.: 161940928

Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Issuer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations